About BSP Biologics

IVF Statement

BSP Biologics is a biotechnology company advancing Bio-Serum Particles (BSPs), a novel class of autologous, cell-free biologic preparations designed for applications in assisted reproductive technologies, including in vitro fertilization (IVF). BSPs are derived from a patient's own blood and contain a diverse profile of proteins, lipids, and nucleic acids associated with intercellular communication and tissue homeostasis.

Built on a proprietary platform for controlled processing and analytical characterization, BSP Biologics is developing approaches to integrate cell-derived signaling biology into IVF. The Bio-Serum Particle platform is designed to provide a personalized solution that integrates seamlessly into existing IVF clinical workflows.

Autologous cell-free regenerative biology illustration

OBGYN / Women's Health Statement

BSP Biologics is a biotechnology company advancing Bio-Serum Particles (BSPs), a novel class of autologous, cell-free biologic preparations designed for applications in women's health and gynecologic care. BSPs are derived from a patient's own blood and contain a diverse profile of proteins, lipids, and nucleic acids associated with intercellular communication and tissue homeostasis.

Built on a proprietary platform for controlled processing and analytical characterization, BSP Biologics is developing approaches to integrate cell-derived signaling biology into broader gynecologic applications. The Bio-Serum Particle platform is designed to provide a personalized, scalable biologic adjunct that integrates with existing clinical workflows across women's health settings.

Women's health and gynecologic care illustration

Our Mission

The mission of BSP Biologics is to advance women's healthcare and fertility by bringing regenerative medicine into clinical practice through precision biologic solutions, developing next-generation, cell-derived therapies that are scientifically rigorous, clinically relevant, and future-focused.

Platform & IVF Integration

Our platform leverages patient-derived biologic material to support assisted reproductive technologies within a controlled and standardized framework. By utilizing autologous, cell-free components, BSP Biologics is designed to prioritize biologic compatibility while reducing variability and maintaining a strong safety profile.

BSP Biologics is developing approaches to integrate regenerative, cell-derived signaling biology into IVF, offering a personalized and scalable platform aligned with existing clinical workflows. Our processes emphasize consistency, sterility, and minimal manipulation, resulting in acellular, ready-to-use preparations developed in alignment with FDA 21 CFR 1271 / 361 HCT/P regulatory principles.